I was expecting a reacceleration of growth for UiPath in the second half of FY2023 — management expects otherwise. Short-term macro uncertainty and weaker-than-expected guidance led to investors ...

Initiate on UiPath Inc. at Neutral with a $15 PT, citing resilient cloud ARR growth and enterprise customer expansion, but competitive intensity and CEO transition limit near-term upside. FY26E and ...

UiPath (NYSE: PATH) is a tiny company compared to Microsoft. The stock of the maker of robotic process automation (RPA) software is only worth $7.2 billion, while the diversified tech titan is worth a ...

UiPath’s latest earnings report exceeded analysts’ expectations. But it significantly reduced its revenue and operating profit guidance for the year. Its CEO also abruptly stepped down. Those headline ...